COVID-19 Daily: Early Remdesivir Data Published, World Leader Recovers
Compassionate Use of Remdesivir More than two thirds of severely ill COVID-19 patients improved after being given the experimental drug remdesivir (Gilead Sciences, Inc), according to an analysis published in the New England…
